The long-awaited American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines were recently released at AHA 2018 in Chicago. This update can be described as an amalgamation of various previous guidelines and highlights the growing complexity of lipid management. In this post, we highlight some of the most important changes in the latest update.
Propofol-Induced Myocardial Depression: Does This Really Exist?
In the intensive care setting, propofol is a commonly used medication for management of sedation in mechanically ventilated, critically ill patients. However, intensivists often select dexmedetomidine over propofol in patients with cardiovascular disease due to concern for cardiac adverse effects such as myocardial depression. In this blog, I’ll be discussing three important considerations before accepting propofol-induced myocardial depression as clinically significant.